Thursday, June 4, 2020 -
Print Edition

Israeli company claims cancer cure

Breast cancer research lab at Hadassah University Hospital in Jerusalem.

Breast cancer research lab at Hadassah University Hospital in Jerusalem.

JERUSALEM — A team of scientists at a biotech company in Israel claimed that they will have a cure for cancer — all cancer — within a year.

Their claims were shot down by fellow scientists.

In recent articles in Israel and the US, Accelerated Evolution Biotechnologies Ltd., or AEBi, which was founded in 2000 from the ITEK Weizmann technology incubator, announced that a new treatment being developed by the company would offer a complete cure for cancer with “no or minimal side-effects at a much lower cost than most other treatments on the market.”

The treatment, according to Dan Aridor, chairman of the board of AEBi, and CEO Dr. Ilan Morad — which they call MuTaTo, or multi-target toxin — works essentially like a cancer antibiotic, they told the Jerusalem Post. They said the results of pre-clinical trials have been very good.

But fellow scientists quickly rejected the claims, calling them “spurious,” “highly irresponsible,” “unsubstantiated” and even “cruel.”

The skeptical scientists note that the research group has not published any findings to back up their claims, as is traditional in the science community.

Morad told the Times of Israel last week that it has not published its research in medical journals because it “can’t afford” to do so.

But reputable scientific journals, that are peer reviewed and highly respected, do not charge to publish serious scientific research, though the process can be rigorous.

Writing in Forbes, Victoria Forster, a cancer researcher and child cancer survivor, called AEBi less than forthcoming with information about their alleged cure.

“Delving into what the company does supply, there are two graphs and some pictures taken down a microscope, much less than I provided from a six-week undergraduate research project a decade ago,” she wrote.

She also calls a claim that one cure will work for all of the over 200 different types of cancer out there a “huge red flag” that such a claim is “highly unlikely.”

Meanwhile, she notes, the American Cancer Society published a blog article from their deputy chief medical officer explaining why the company’s claims are unlikely to be true, including that their approach isn’t unique and that other similar approaches have failed.

The CEO of the Israel Advanced Technology Industries group said the whole situation has “damaged the image of Israel’s life sciences industry.”

So far, the tests have also only been conducted on mice, not on humans, although the scientists told the Jerusalem Post that their results are “consistent and repeatable.”

The company told the Times of Israel that it plans to advance its research and get to clinical trials as fast as possible.

2 thoughts on “Israeli company claims cancer cure

  1. brian claek

    Take away billions of dollars in big pharma In America in cancer medications and a cure arrived in 2010. Imagine that. Hey, maybe even some rich crook will buy these guys and put em under, make em go away, as he’s vested multi millions in the most profitable cancer drug. Wouldn’t that be something…money …money

  2. Rick Donaldson

    IF they have a cure… which is yet to be seen… why denigrate them? Scientists out there KNOW and understand that “can’t afford to publish” does not mean in terms of money, it means “in terms of information”. Putting the data out there, while unproven is giving away the keys to humanity. A way to give those who want to suppress a cure a chance to cover their tracks and make the ‘cure’ vanish.

    Instead, doctors the world over should be jumping on this to HELP these guys. If they fail to bring fort a cure, then that’s what it was, a hoax. And if they do, it’s shared.


Leave a Reply


Dear valued reader,

During these very difficult times that we’re all experiencing, why does the Intermountain Jewish News matter more than ever?

  • It connects us when we feel separated and surrounded by chaos. With the IJN, we are not alone. We are all in this together as a community.
  • It is our trusted, distinctive news source. The IJN works hard to provide facts, not sensationalism.
  • It brings you the impact of COVID-19 on the Colorado Jewish community.

Like other small businesses and media companies, the IJN is also being impacted in an unprecedented way by effects of the coronavirus.

That’s Why Your Help Is Needed Today.

Please subscribe today or purchase a gift subscription — an online gift is social distancing.

If you’re already a subscriber, you can also donate to the IJN to support our mission of providing quality and comprehensive journalism to the Colorado Jewish community.


Rabbi Hillel Goldberg
Editor & Publisher

Shana R. Goldberg
Assistant Publisher